The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update
Open accessAbstract
There have been considerable recent advances towards a better understanding of the complex cellular and molecular network underlying liver fibrogenesis. Recent data indicate that the termination of fibrogenic processes and the restoration of deficient fibrolytic pathways may allow the reversal of advanced fibrosis and even cirrhosis. Therefore, efforts have been made to better clarify the cellular and molecular mechanisms that are involved in liver fibrosis. Activation of hepatic stellate cells (HSCs) remains a central event in fibrosis, complemented by other sources of matrix-producing cells, including portal fibroblasts, fibrocytes and bone marrow-derived myofibroblasts. These cells converge in a complex interaction with neighboring cells to provoke scarring in response to persistent injury. Defining the interaction of different cell types, revealing the effects of cytokines on these cells and characterizing the regulatory mechanisms that control gene expression in activated HSCs will enable the discovery of new therapeutic targets. Moreover, the characterization of different pathways associated with different etiologies aid in the development of disease-specific therapies. This article outlines recent advances regarding the cellular and molecular mechanisms involved in liver fibrosis that may be translated into future therapies. The pathogenesis of liver fibrosis associated with alcoholic liver disease, non-alcoholic fatty liver disease and viral hepatitis are also discussed to emphasize the various mechanisms involved in liver fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–230 of 230
Leptin and liver tissue repair: Do rodent models provide the answers?
Marra, F. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.002 · Cited by 40
Iizuka, M., Murata, T., Hori, M., & Ozaki, H. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00350.2010 · Cited by 40
Iron metabolic disorder in chronic hepatitis C : Mechanisms and relevance to hepatocarcinogenesis
Hino, K., Nishina, S., & Hara, Y. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12243 · Cited by 38
Human platelets inhibit liver fibrosis in severe combined immunodeficiency mice
Takahashi, K., Murata, S., Fukunaga, K., & Ohkohchi, N. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i32.5250 · Cited by 38
Thymus cell antigen‐1‐expressing cells in the oval cell compartment†
Yovchev, M. I., Zhang, J., Neufeld, D. S., Grozdanov, P. N., & Dabeva, M. D. (2009) · Hepatology · doi:10.1002/hep.23012 · Cited by 37
Zvibel, I., Atias, D., Phillips, A. T., Halpern, Z., & Oren, R. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.48 · Cited by 37
Skin-derived multipotent stromal cells – an archrival for mesenchymal stem cells
Vishnubalaji, R., Al-Nbaheen, M. S., Kadalmani, B., Aldahmash, A. M., & Ramesh, T. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1471-z · Cited by 36
Li, Y., Ni, S.-Y., Meng, Y., Shi, X., Zhao, X., Luo, H., & Li, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076289 · Cited by 36
Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C
Hora, C., Negro, F., Leandro, G., Oneta, C. M., Rubbia‐Brandt, L., Muellhaupt, B., Helbling, B., Malinverni, R., Gonvers, J., Dufour, J., et al. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01608.x · Cited by 35
Arciello, M., Gori, M., & Balsano, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/971024 · Cited by 34
McCarty, M. F. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.06.029 · Cited by 32
Endothelin and hepatic wound healing
Khimji, A.-K., & Rockey, D. C. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.03.005 · Cited by 32
den Hartog, G. J. M., Qi, S., van Tilburg, J. H. O., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.12.033 · Cited by 30
Shi, Z., & Rockey, D. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.164863 · Cited by 26
DNA methylation: New therapeutic implications for hepatic fibrosis
Bian, E., Huang, C., Wang, H., Wu, B., Zhang, L., Lv, X., & Li, J. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.10.007 · Cited by 25
Korah, T. E., El-Sayed, S., Elshafie, M. K., Hammoda, G. E., & Safan, M. A. (2013) · World Journal of Hepatology · doi:10.4254/wjh.v5.i2.74 · Cited by 25
Novitskiy, G., Ravi, R. K., Potter, J. J., Rennie-Tankersley, L., Wang, L., & Mezey, E. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh116 · Cited by 25
Chouteau, P., Defer, N., Florimond, A., Caldéraro, J., Higgs, M. R., Gaudin, A., Mérour, E., Dhumeaux, D., Lerat, H., & Pawlotsky, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.019 · Cited by 24
Sitia, G., Bona, A. D., Bagaglio, S., Galli, L., Paties, C. T., Uberti‐Foppa, C., Guidotti, L. G., Lazzarin, A., & Morsica, G. (2006) · Antiviral Therapy · doi:10.1177/135965350601100307 · Cited by 22
Liu, T., Wang, P., Cong, M., Xu, Y., Jia, J., & You, H. (2013) · Bioscience Reports · doi:10.1042/bsr20130033 · Cited by 22
Kida, Y., Xia, Z., Zheng, S., Mordwinkin, N. M., Louie, S. G., Zheng, S. G., Feng, M., Shi, H., Duan, Z., & Han, Y.-P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026644 · Cited by 21
RANTES antagonism: A promising approach to treat chronic liver diseases
Affò, S., & Bataller, R. A. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.04.023 · Cited by 21
Szatmári, I., Iacovino, M., & Kyba, M. (2010) · Stem Cells · doi:10.1002/stem.484 · Cited by 18
Moreno‐Alvarez, P., Sosa‐Garrocho, M., Briones-Orta, M. A., González‐Espinosa, C., Medina‐Tamayo, J., Molina‐Jijón, E., Pedraza‐Chaverrí, J., & Macías‐Silva, M. (2010) · Cell Biology International · doi:10.1042/cbi20090074 · Cited by 17
Takahashi, K., Sasabe, N., Ohshima, K., Kitazato, K. T., Kato, R., Masuda, Y., Tsurumaki, M., Obama, T., Okudaira, S.-I., Aoki, J., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m004648 · Cited by 16
Angiotensin II Induces Endothelin-1 Expression in Human Hepatic Stellate Cells
He, C., Miao, X., Li, J., & Qi, H. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2685-y · Cited by 15
The liver X receptor in hepatic stellate cells: a novel antifibrogenic target?
Mallat, A., & Lotersztajn, S. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.018 · Cited by 11
The role of endothelin-1 and its receptor blockers on the liver function
Michalski, Ł., Kleniewska, P., Piechota-Polańczyk, A., & Gorąca, A. (2012) · General Physiology and Biophysics · doi:10.4149/gpb_2012_046 · Cited by 8
Does HIV-1 co-receptor tropism correlate with fibrosis progression in HIV/HCV co-infected patients?
Saracino, A., Bruno, G., Scudeller, L., Punzi, G., Lagioia, A., Ladisa, N., Monno, L., & Angarano, G. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.12.009 · Cited by 7
Key role for αv integrins in myofibroblasts in liver fibrosis
Ray, K. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.227 · Cited by 5
Cited by
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
“diseases lead to damaged hepatocytes and infiltration of immune cells that activate trans-differentiation of Hepatic stellate cells (HSCs) into collagen-producing myofibroblasts [8,9].”
BackgroundInfluentialTGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Dewidar, B., Meyer, C., Dooley, S., & Meindl-Beinker, A. N. (2019) · Cells · doi:10.3390/cells8111419 · Cited by 837
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
Zhang, C.-Y., Yuan, W.-G., He, P., Lei, J.-H., & Wang, C.-X. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i48.10512 · Cited by 594
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
Haas, J. T., Francque, S., & Staels, B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105331 · Cited by 394
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
Fabregat, I., & Caballero-Díaz, D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00357 · Cited by 351
Metadata
- Authors
- Elpek, G. Ö.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014
- Volume
- 20
- Issue
- 23
- Pages
- 7260
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2020960905
- Cited by
- 382
- References
- 230
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.